rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2010-7-26
|
pubmed:abstractText |
Hexyl aminolevulinate (HAL) is a long-chained 5-aminolevulinic acid-ester that has been proposed as a novel photosensitizing agent to methyl aminolevulinate (MAL) in topical photodynamic therapy (PDT). The more lipophilic HAL, may improve treatment outcome for non-melanoma skin cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1600-0625
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
19
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
e166-72
|
pubmed:meshHeading |
pubmed-meshheading:20100196-Administration, Topical,
pubmed-meshheading:20100196-Aminolevulinic Acid,
pubmed-meshheading:20100196-Animals,
pubmed-meshheading:20100196-Carcinoma, Squamous Cell,
pubmed-meshheading:20100196-Disease Models, Animal,
pubmed-meshheading:20100196-Dose-Response Relationship, Drug,
pubmed-meshheading:20100196-Female,
pubmed-meshheading:20100196-Mice,
pubmed-meshheading:20100196-Mice, Hairless,
pubmed-meshheading:20100196-Neoplasms, Radiation-Induced,
pubmed-meshheading:20100196-Photochemotherapy,
pubmed-meshheading:20100196-Photosensitizing Agents,
pubmed-meshheading:20100196-Skin Neoplasms,
pubmed-meshheading:20100196-Treatment Outcome,
pubmed-meshheading:20100196-Ultraviolet Rays
|
pubmed:year |
2010
|
pubmed:articleTitle |
Photodynamic therapy with topical methyl- and hexylaminolevulinate for prophylaxis and treatment of UV-induced SCC in hairless mice.
|
pubmed:affiliation |
Department of Dermatology, Bispebjerg Hospital, Copenhagen, Denmark. katrinetogsverd@hotmail.com
|
pubmed:publicationType |
Journal Article,
Comparative Study
|